ABOUT US
Xinxiang Ruicheng Technology Co., Ltd. (hereinafter referred to as "Ruicheng Technology"), established in 2000 and headquartered in the eastern section of Qinglong Road, Xinxiang Economic Development Zone, is a high-tech enterprise integrating R&D, production, and sales. The company focuses on the development and industrialization of nucleoside and antiviral APIs and vitamin intermediates. Its core products include nucleoside pharmaceutical intermediates such as adenine, cytosine, tetraacetylribose, and hypoxanthine, which are widely used in the production of antiviral APIs.
The company possesses provincial-level R&D center qualifications and has established joint laboratories with universities such as Huazhong University of Science and Technology and Tianjin University of Science and Technology. Its R&D investment has maintained a leading position in the industry for many consecutive years. The company has passed ISO triple management system certification (quality, environment, and occupational health) and obtained Indonesian HALAL and Kosher certifications, ensuring its products meet international mainstream market access standards.
Xinxiang Ruicheng Technology – Pharmaceutical API & Nucleoside Intermediates Supplier
We supply high-purity chemical raw materials for pharmaceutical manufacturing, meeting international quality standards.
In 2015, Ruicheng Technology was recognized as a high-tech enterprise. In 2016, it was listed on the National Equities Exchange and Quotations (NEEQ) (stock code: 836437), and in 2018, it entered the Innovation Layer. In 2017, the company established a subsidiary, Xinxiang Ruinuo Pharmaceutical, leveraging the resources of the Xinlianxin Group to develop green chemical intermediates and build a vertically integrated industrial chain from basic raw materials to high-value-added products. In 2021, it was selected as a leading innovative enterprise in Henan Province. In 2022, it put into production 5,000 tons of high-purity solvents, and in 2023, it put into production 8,000 tons of α-acetyl-γ-butyrolactone.
Ruicheng is a pharmaceutical API manufacturer and global API supplier, dedicated to the development and production of nucleoside and antiviral API intermediates.
With advanced R&D capabilities and strict quality control systems, we supply high-purity chemical raw materials for pharmaceutical manufacturing, supporting drug development, clinical research, and large-scale production.
As a trusted API supplier in China, Ruicheng serves customers across Europe, America, Japan, South Korea, India, and Southeast Asia, delivering stable quality, regulatory-compliant pharmaceutical intermediates and custom API synthesis solutions.
In the future, it will continue to expand its overseas markets and enhance its global competitiveness through technological advantages and compliance certifications.
Corporate Culture:
Adhering to the principle of "market-oriented, talent-based, and product-supported," the company continuously optimizes its management system, builds a knowledgeable and professional team, and is committed to becoming an innovative leader in the global pharmaceutical intermediates field.
